Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Achieve Life Sciences, Inc. (ACHV) Balance Sheet

As of 2026-06-30 (10-Q), Achieve Life Sciences, Inc. (ACHV) reported total assets of $190.4M, total liabilities of $205.1M and shareholders' equity of -$14.7M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $48.0M.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

ACHVAchieve Life Sciences, Inc.Follow ACHV — free
Biotechnology · Healthcare
—
Price chart with a free account
Market cap
667.8M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
5 Nov, in 12 days
LineFY2011
Dec 11
FY2012
Dec 12
FY2013
Dec 13
FY2014
Dec 14
FY2015
Dec 15
FY2016
Dec 16
FY2017
Dec 17
FY2018
Dec 18
FY2019
Dec 19
FY2020
Dec 20
FY2021
Dec 21
FY2022
Dec 22
FY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
Latest
Jun 26
Trend
Cash and equivalents28.518.114.627.90.10.05.39.516.735.943.024.815.512.820.948.0
Short-term investments36.457.324.619.220.910.2—5.1—————21.615.5139.3
Receivables0.40.78.75.70.00.50.00.00.0———————
Current assets66.980.253.955.857.30.05.915.517.337.044.627.317.036.539.9188.3
Total assets68.082.055.756.358.23.89.919.121.140.347.530.019.438.641.8190.4
Current liabilities30.811.614.922.220.73.12.03.32.92.94.621.620.86.79.1197.7
Total liabilities37.115.818.522.220.83.22.03.33.03.019.521.720.817.720.3205.1
Shareholders' equity30.966.237.234.11.80.615.815.818.137.328.08.3-1.420.921.5-14.7

USD millions · SEC XBRL

Achieve Life Sciences, Inc. — questions

How much cash does Achieve Life Sciences, Inc. have?
$48.0M in cash and cash equivalents as of 2026-06-30.
What are Achieve Life Sciences, Inc.'s total assets?
$190.4M as of 2026-06-30.
What is Achieve Life Sciences, Inc.'s shareholders' equity?
-$14.7M as of 2026-06-30.

Every figure on this page comes from Achieve Life Sciences, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.